Press release
Hepatitis D Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Eiger Biopharmaceuticals, Arrowhead Pharmaceuticals, Antios Therapeutics, PharmaEsse
Hepatitis D Pipeline Analysis
According to DelveInsight, the Hepatitis D treatment pipeline includes over six leading companies actively engaged in the development of more than six therapeutic candidates.
Hepatitis D Overview:
Hepatitis D, also known as delta hepatitis, is a liver infection caused by the hepatitis D virus (HDV) and occurs only in individuals already infected with the hepatitis B virus (HBV). Transmission happens through contact with infected blood or bodily fluids. The infection can be either acute and short-lived or develop into a chronic condition, often resulting in serious health issues, including permanent liver damage and potentially death. Individuals may contract hepatitis B and D at the same time (coinfection) or acquire hepatitis D after an existing hepatitis B infection (superinfection). Although there is no vaccine specifically for hepatitis D, vaccination against hepatitis B effectively prevents HDV infection as well.
Request for a detailed insights report on Hepatitis D pipeline insights [https://www.delveinsight.com/report-store/hepatitis-d-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
"Hepatitis D Pipeline Insight 2025" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Hepatitis D Therapeutics Market.
Key Takeaways from the Hepatitis D Pipeline Report
*
DelveInsight's Hepatitis D pipeline report depicts a robust space with 25+ active players working to develop 30+ pipeline therapies for Hepatitis D treatment.
*
In October 2025, Bluejay Therapeutics announces upcoming data presentations on Chronic Hepatitis D (CHD) and Chronic Hepatitis B (CHB) at the 2025 American Association for the Study of Liver Diseases (AASLD) The Liver Meeting Registered .
*
In September 2023, Eiger BioPharmaceuticals announced the discontinuation of its Phase III LIMT-2 study of peginterferon lambda in patients with chronic hepatitis D. This decision was made following a recommendation from the Data Safety Monitoring Board (DSMB) after their routine safety review.
*
Key Hepatitis D companies such as Eiger Biopharmaceuticals, Arrowhead Pharmaceuticals, Antios Therapeutics, PharmaEssentia, REPLICor, SomaGenics, Vir Biotechnology, VLP Biotech, and others are evaluating new drugs for Hepatitis D to improve the treatment landscape.
*
Promising Hepatitis D pipeline therapies in various stages of development include Lonafarnib, JNJ 73763989, and others.
Hepatitis D Pipeline Analysis
The report provides insights into:
*
The report provides detailed insights into the key companies that are developing therapies in the Hepatitis D Market.
*
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Hepatitis D treatment.
*
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Hepatitis D market.
Download our free sample page report on Hepatitis D pipeline insights [https://www.delveinsight.com/sample-request/hepatitis-d-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Hepatitis D Emerging Drugs
*
Lonafarnib: Eiger Biopharmaceuticals
*
JNJ 73763989: Arrowhead Pharmaceuticals
Hepatitis D Companies
Approximately six major companies are working on developing treatments for Hepatitis D. Among them, Eiger Biopharmaceuticals has the most advanced drug candidates, currently in Phase III of clinical development.
DelveInsight's report covers around 22+ products under different phases of clinical development like
*
Late stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I) along with the details of
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
Hepatitis D pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
*
Intravenous
*
Subcutaneous
*
Oral
*
Intramuscular
Hepatitis D Products have been categorized under various Molecule types such as
*
Monoclonal antibody
*
Small molecule
*
Peptide
Download Sample Pages to Get an in-depth Assessment of the Emerging Hepatitis D Therapies and Key Companies: Hepatitis D Clinical Trials and advancements [https://www.delveinsight.com/report-store/hepatitis-d-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Hepatitis D Pipeline Therapeutic Assessment
- Hepatitis D Assessment by Product Type
- Hepatitis D By Stage
- Hepatitis D Assessment by Route of Administration
- Hepatitis D Assessment by Molecule Type
Download Hepatitis D Sample report to know in detail about the Hepatitis D treatment market @ Hepatitis D Therapeutic Assessment [https://www.delveinsight.com/sample-request/hepatitis-d-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Table of Content
1. Report Introduction
2. Executive Summary
3. Hepatitis D Current Treatment Patterns
4. Hepatitis D - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Hepatitis D Late-Stage Products (Phase-III)
7. Hepatitis D Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Hepatitis D Discontinued Products
13. Hepatitis D Product Profiles
14. Hepatitis D Key Companies
15. Hepatitis D Key Products
16. Dormant and Discontinued Products
17. Hepatitis D Unmet Needs
18. Hepatitis D Future Perspectives
19. Hepatitis D Analyst Review
20. Appendix
21. Report Methodology
Request the Sample PDF to Get Detailed Insights About the Hepatitis D Pipeline Reports Offerings [https://www.delveinsight.com/report-store/hepatitis-d-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=hepatitis-d-clinical-trials-companies-therapeutic-assessment-therapies-treatment-algorithm-pipeline-analysis-eiger-biopharmaceuticals-arrowhead-pharmaceuticals-antios-therapeutics-pharmaesse]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hepatitis D Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Eiger Biopharmaceuticals, Arrowhead Pharmaceuticals, Antios Therapeutics, PharmaEsse here
News-ID: 4082284 • Views: …
More Releases from ABNewswire
Denver's Best Appliance Repair Responds to Rising Demand for Emergency Appliance …
Denver's Best Appliance Repair expands emergency services across the Denver metro with same-day repairs, 7-day availability, 5-year parts warranty, and professional licensed technicians serving residential and commercial clients.
Household appliance failures don't follow a schedule. When a refrigerator stops cooling in the middle of summer or a washing machine floods a basement on a Sunday evening, families need immediate help. Denver's Best Appliance Repair has responded to this growing need by…
Oak Hill Clinic Reaches 30,000 Client Milestone with Results-Driven Deep Tissue …
Deep Relief in Oak Hill, Austin, has served 30,000 clients through specialized massage, chiropractic, and acupuncture care. The clinic accepts insurance and focuses on results-driven treatments for pain relief.
Deep Relief, an Oak Hill-based wellness clinic, has achieved a significant milestone by serving more than 30,000 clients seeking Relief from chronic pain, muscle tension, and mobility issues. The clinic's success stems from its commitment to advanced, results-focused bodywork that goes beyond…
Vertex Fleet Expands Nationwide Network to Combat Growing Trailer Drop Yard Shor …
Vertex Fleet announces major expansion of secure parking facilities nationwide, addressing the critical shortage of commercial vehicle storage with 15+ new locations featuring 24/7 security and technology-driven access.
The freight and logistics industry faces a mounting crisis as demand for secure parking spaces continues to outpace supply across the United States. Vertex Fleet [https://www.vertexfleet.com/], a leading provider of industrial outdoor storage solutions, has announced significant expansion plans to address this critical…
HVAC in Denver Sees Service Enhancement as Denver's Best Heating and AC Repair L …
Denver's Best Heating and AC Repair expands 24/7 emergency services across 23 metro cities, offering A+ rated heating, cooling, and commercial HVAC solutions with rapid response times and multi-brand expertise.
Denver's Best Heating and AC Repair [https://www.denversbestheatingandacrepair.com/]has expanded its service capabilities to meet growing demand for reliable heating and cooling solutions across the Denver Metro area. The A+ rated contractor now provides 24/7 emergency response services to 23 cities, addressing critical…
More Releases for Hepatitis
POC Diagnostics Encourages Timely Hepatitis Testing Amid WHO's Hepatitis D Carci …
Birmingham, 18th September, 2025:
The World Health Organization (WHO) recently classified Hepatitis D as a carcinogen and raised a global concern about its link to liver cancer. In response to this, POC Diagnostic, one of the renowned and leading providers of modern medical testing solutions, urges both individuals and healthcare providers to prioritise early Hepatitis recognition.
Timely detection of Hepatitis infections is critical to prevent severe health complications. POC Diagnostics is…
Driving Viral Hepatitis Market Growth in 2025: The Role of Elevated Prevalence O …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Viral Hepatitis Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the viral hepatitis market has experienced consistent growth. It is projected to increase from $16.21 billion in 2024 to $16.93 billion in 2025, representing a compound annual growth rate (CAGR)…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Hepatitis D Market - Defeating Hepatitis D Together: Uniting Against the Silent …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Hepatitis D Market.
Hepatitis D Market: https://www.growthplusreports.com/report/hepatitis-d-market/9196
The Hepatitis D Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Hepatitis C Testing Market - Advancing Hepatitis C Elimination Strategies: Embra …
Newark, New Castle, USA: The "Hepatitis C Testing Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hepatitis C Testing Market: https://www.growthplusreports.com/report/hepatitis-c-testing-market/7962
This latest report researches the industry structure,…
